Australia Gamma Knife Market Poised for Robust Growth with 8.4% CAGR by 2033 | FMI

Posted on 2024-10-02 by Future Market Insights in Healthcare // 0 Comments

The australia gamma knife market is projected to witness remarkable growth over the next decade, with a compound annual growth rate (CAGR) of 8.4% from 2023 to 2033. This promising expansion underscores the increasing demand for non-invasive neurosurgery technologies across the country.

Rising Demand for Precision Neurosurgery:

The Gamma Knife, a cutting-edge technology used in radiosurgery, has gained significant traction due to its precision in treating brain disorders such as brain tumors, vascular malformations, and functional diseases like trigeminal neuralgia. This device allows for highly targeted treatment without the need for traditional invasive surgery, leading to fewer complications, reduced recovery times, and improved patient outcomes.

Key Growth Drivers:

Several factors are contributing to the robust growth of the Gamma Knife market in Australia:

Technological Advancements: Continuous innovations in radiosurgery are enhancing the effectiveness and safety of Gamma Knife procedures, encouraging wider adoption among healthcare providers.
Rising Prevalence of Neurological Disorders: As Australia’s aging population grows, so does the prevalence of neurological conditions. This demographic shift is fueling the demand for advanced treatment options like Gamma Knife surgery.
Increased Healthcare Investment: The Australian government’s ongoing investment in healthcare infrastructure and medical technologies is creating a supportive environment for the expansion of radiosurgery services across the nation.

Outlook for 2033:

The forecasted growth of the Gamma Knife market highlights the increasing importance of non-invasive treatment methods in Australia’s healthcare landscape. By 2033, this market is expected to significantly impact the neurosurgery field, offering enhanced treatment options for patients while reducing the burden on traditional surgical procedures.

As the market continues to expand, Australia’s healthcare system is well-positioned to become a leader in advanced radiosurgery, improving the quality of care for patients suffering from complex neurological conditions.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Key Takeaways from the Market Study:

Global gamma knife market was valued at USD 313.8 million by 2022-end.
From 2018 to 2022, the market demand expanded at a CAGR of 7.2%.
The market in India is expected to expand at a CAGR of 11.4% through 2033.
By disease, the brain metastases segment to account for a share of 69.2% in 2033.
From 2023 to 2033, gamma knife market is expected to flourish at a CAGR of 7.6%.
By 2033, the market value of gamma knife is expected to reach USD 702.5 million.

Gamma knife can complement regenerative medicine and stem cell therapies by providing a precise means of targeting specific areas in the brain for treatment, remarks an FMI analyst.

Competitive Landscape:

Prominent players in the gamma knife market are Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, and Hitachi, Ltd., among others.

Recent Developments:

In 2023, Varian announced the launch of its new Varian gamma knife icon system. The system features a more compact design, improved image guidance, and a faster treatment delivery system.
In 2022, Akesis announced the launch of its new Akesis Galaxy SRS system. The system is the first and only gamma knife system to use a linear accelerator instead of a cobalt 60 source.

Segmentation Analysis of the Gamma Knife Market

By Disease Indication:

Brain Metastasis
Cancer
Arteriovenous Malformation
Trigeminal Neuralgia
Others

By Anatomy:

Head
Neck
Other Body Parts

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick